Sixteen-year Prognosis of Treatment-naive Patients with Hepatitis C Infection

dc.authorid0000-0002-3341-925X
dc.authorid0000-0001-5996-8639
dc.authorid0000-0003-0230-9127
dc.authorid0000-0002-3428-6137
dc.authorid0000-0003-0398-9216
dc.authorid0000-0002-8205-4752
dc.contributor.authorKaracaer, Zehra
dc.contributor.authorTosun, Selma
dc.contributor.authorBatirel, Ayse
dc.contributor.authorAcar, Ali
dc.contributor.authorCelik, Neslihan
dc.contributor.authorUguz, Mustafa
dc.contributor.authorYavuz, Songul
dc.date.accessioned2025-05-10T19:52:22Z
dc.date.issued2019
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjectives: In this study, we aimed to evaluate the clinical course of treatment-naive patients infected with hepatitis C virus (HCV) who were followed up in various centers in Turkey. Materials and Methods: This was a retrospective study performed with the participation of 15 centers. Patients aged 18 years and older with HCV infection were included. Results: A total of 391 treatment-naive patients infected with HCV were included in this study. During the follow-up period, the final values of alanine aminotransferase, aspartate transaminase, and total protein were significantly decreased when compared to the initial values (p<0.001, p<0.001, and p=0.005, respectively). In the study group, 19.2% of the patients underwent liver biopsy and 4.1% underwent transient elastography (FibroScan). An increased histological activity index (HAI) score and fibrosis in the second biopsy were observed in one patient, only increased HAI in two patients and increased fibrosis in one patient, as shown on the FibroScan. In the 16 years of the study period, cirrhosis was radiologically detected in only one patient. Conclusion: Even if rapid progression is not observed, close monitoring of the clinical findings related to liver failure and fibrosis with invasive or non-invasive methods may be useful.
dc.identifier.doi10.4274/vhd.galenos.2018.0026
dc.identifier.endpage24
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue1
dc.identifier.scopusqualityN/A
dc.identifier.startpage19
dc.identifier.trdizinid341477
dc.identifier.urihttps://doi.org/10.4274/vhd.galenos.2018.0026
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/341477
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12390
dc.identifier.volume25
dc.identifier.wosWOS:000466134600004
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectHepatitis C
dc.subjectnaive
dc.subjectprognosis
dc.titleSixteen-year Prognosis of Treatment-naive Patients with Hepatitis C Infection
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12390.pdf
Boyut:
126.52 KB
Biçim:
Adobe Portable Document Format